Variation in SLC19A3 and Protection From Microvascular Damage in Type 1 Diabetes
Massimo Porta(University of Turin), Per‐Henrik Groop(University of Helsinki), Niina Sandholm(University of Helsinki), Valma Harjutsalo(Research Council of Finland), Andrew D. Paterson(Hospital for Sick Children), L Borio, Ronald Klein(University of Wisconsin–Madison), S. Mohsen Hosseini(University of Toronto), Barbara E.K. Klein(University of Wisconsin–Madison), Carol Forsblom(University of Helsinki), Kustaa Hietala(Helsinki University Hospital), Iiro Toppila(University of Helsinki)
STM:n Hallinnonalan avoin julkaisuarkisto (Julkari)
January 1, 2016
Cited by 14
Related Papers
Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis
|The Lancet Global Health|2014|5.2k
Retinopathy in Diabetes
|Diabetes Care|2004|1.1k
Renal and Retinal Effects of Enalapril and Losartan in Type 1 Diabetes
|New England Journal of Medicine|2009|790